UBS O'Connor’s Inspire Medical Systems INSP Stock Holding History

UBS O'Connor’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,000	Closed	-$85.5K	–	366
2025 Q2	$85.5K	Buy	+10,000	New	+$1.45M	﹤0.01%	320

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS O'Connor's INSP Position: Q3 2025 in Review

UBS O'Connor sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 9,522 shares — an estimated $1.24M sold.

UBS O'Connor first reported a position in INSP in Q3 2022 and held it in 11 quarters. The position peaked at $2.69M in Q2 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

UBS O'Connor reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
UBS O'Connor sold 9,522 Inspire Medical Systems shares in Q3 2025, an estimated $1.24M.
UBS O'Connor first reported a position in Inspire Medical Systems in Q3 2022 and held it in 11 quarters.
UBS O'Connor's Inspire Medical Systems position peaked at $2.69M in Q2 2023.
325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.